Delivery Order SPE2DR25D2013-SPE2DR26F5QQE
- Not listed
- The Defense Logistics Agency awarded a $3,010.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyanocobalamin 500 MCG Sprays on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Cyanocobalamin 500 MCG Sprays with a ceiling value of $4,926.27. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,219.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for Cyanocobalamin 500 MCG sprays, with an ultimate completion date of October 22, 2025. This non-set-aside contract is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement within AmerisourceBergen's broader federal supply relationships. This delivery order is a...
- The Defense Logistics Agency awarded a $7,553.60 delivery order to AmerisourceBergen Drug Corp for Cyanocobalamin 500 MCG Sprays under a firm fixed price contract on September 17, 2025, with an ultimate completion date of September 18, 2025. The award was not set aside for small businesses or other designated groups, indicating competitive selection. Performance will be executed from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Cyanocobalamin 500 MCG sprays, with a ceiling value of $2,214.06 and an ultimate completion date of November 25, 2025. This is a firm fixed-price delivery order executed without set-aside designation, indicating competitive award. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2024, for the supply of Cyanocobalamin 500 MCG Sprays with a ceiling value of $7,547.93. This firm fixed-price delivery order, which achieved ultimate completion on November 7, 2024, represents a competitive award with no set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's existing...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,920.72, is for the delivery of Cyanocobalamin 500 mcg sprays. It has an ultimate completion date of July 18, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $21,777.56, is for the delivery of Cyanocobalamin 500 MCG sprays. This is a firm fixed-price delivery order contract with a completion date of March 13, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,749.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566769117 - Cyanocobalamin 500 MCG Sprays, with a completion date of December 20, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,903.09 to AmerisourceBergen Drug Corp for Cyanocobalamin 1,000 MCG/ML, a vitamin B12 pharmaceutical product. The contract, which carries a firm fixed price arrangement with no set-aside designation, was competitively awarded and is scheduled for completion by August 11, 2025. AmerisourceBergen will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QQEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,217.67 to AmerisourceBergen Drug Corp for Cyanocobalamin 500 MCG Sprays, with an ultimate completion date of November 26, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order was awarded on November 25, 2025, and represents a routine pharmaceutical procurement to support federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent IDC enables the company to provide pharmaceutical support globally to customers including the Defense Health Agency and U.S. Coast Guard through a flexible contract vehicle that supports the military's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 11/24/25 |